- The recommended dose for treating relapsing forms of MS is 20 mg injected under the skin daily or 40 mg injected under the skin 3 times a week (at least 48 hours apart).
DRUG CLASS AND MECHANISM:
- Glatiramer's mechanism of action is not completely understood. Available data suggests that it may work by modifying immune processes by suppressing T-cells (white blood cells of the immune system) that cause inflammation and destruction of nerves in patients with MS . Glatiramer does not cure MS. It decreases the number of MS flares and lesions in the brain.
- The FDA approved glatiramer in December, 1996.
REFERENCE: FDA Prescribing Information
Quick GuideMultiple Sclerosis (MS) Symptoms and Treatment
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.